Gradient Investments LLC Invests $1.63 Million in Tenet Healthcare Corporation $THC

Gradient Investments LLC bought a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 8,711 shares of the company’s stock, valued at approximately $1,630,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. NewEdge Advisors LLC raised its position in shares of Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after buying an additional 166 shares during the last quarter. Jones Financial Companies Lllp grew its stake in Tenet Healthcare by 299.1% during the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after acquiring an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC bought a new stake in Tenet Healthcare in the 2nd quarter valued at $290,000. Quantbot Technologies LP purchased a new stake in Tenet Healthcare in the 2nd quarter worth $65,000. Finally, Amundi boosted its holdings in shares of Tenet Healthcare by 4,207.8% during the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Trading Up 0.2%

Shares of NYSE THC opened at $262.75 on Monday. Tenet Healthcare Corporation has a 1-year low of $157.58 and a 1-year high of $265.32. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The business’s 50 day moving average is $200.19 and its two-hundred day moving average is $201.43. The stock has a market capitalization of $21.16 billion, a P/E ratio of 10.13, a PEG ratio of 1.00 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the company earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 21.09 EPS for the current year.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, EVP Lisa Y. Foo sold 10,000 shares of the business’s stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $258.03, for a total transaction of $2,580,300.00. Following the transaction, the executive vice president owned 32,053 shares in the company, valued at $8,270,635.59. The trade was a 23.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Paola M. Arbour sold 10,878 shares of the firm’s stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $243.90, for a total transaction of $2,653,144.20. Following the completion of the sale, the executive vice president owned 18,413 shares of the company’s stock, valued at $4,490,930.70. This trade represents a 37.14% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 33,953 shares of company stock valued at $7,841,125. Insiders own 0.97% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on THC shares. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, August 3rd. Morgan Stanley raised their price target on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a report on Monday, July 27th. Piper Sandler set a $308.00 price objective on Tenet Healthcare in a report on Monday, July 27th. Stephens reissued an “overweight” rating and issued a $285.00 target price on shares of Tenet Healthcare in a report on Monday, July 27th. Finally, KeyCorp decreased their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $271.00.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.